Literature DB >> 34917247

Novel Compounds for Preventing SARS-CoV-2 Viral Replication and Treating COVID-19.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 34917247      PMCID： PMC8667055          DOI： 10.1021/acsmedchemlett.1c00610

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  6 in total

1.  Recent Insights into Emerging Coronavirus: SARS-CoV-2.

Authors:  Zifang Shang; Siew Yin Chan; William J Liu; Peng Li; Wei Huang
Journal:  ACS Infect Dis       Date:  2020-12-09       Impact factor: 5.084

Review 2.  Reducing SARS-CoV-2 pathological protein activity with small molecules.

Authors:  Donata Pluskota-Karwatka; Marcin Hoffmann; Jan Barciszewski
Journal:  J Pharm Anal       Date:  2021-04-05

Review 3.  Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection.

Authors:  Koen Vandyck; Jerome Deval
Journal:  Curr Opin Virol       Date:  2021-04-27       Impact factor: 7.090

Review 4.  Potential SARS-CoV-2 main protease inhibitors.

Authors:  Riddhidev Banerjee; Lalith Perera; L M Viranga Tillekeratne
Journal:  Drug Discov Today       Date:  2020-12-09       Impact factor: 7.851

Review 5.  An overview of human proteins and genes involved in SARS-CoV-2 infection.

Authors:  Zohreh Jahanafrooz; Zhishan Chen; Jiandong Bao; Hongzhi Li; Loren Lipworth; Xingyi Guo
Journal:  Gene       Date:  2021-09-14       Impact factor: 3.688

Review 6.  Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors?

Authors:  Sk Abdul Amin; Suvankar Banerjee; Shovanlal Gayen; Tarun Jha
Journal:  Eur J Med Chem       Date:  2021-02-13       Impact factor: 6.514
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.